Carmenta Bioscience Receives $2,000,000 Seed Financing Round

  • Feed Type
  • Date
    8/8/2013
  • Company Name
    Carmenta Bioscience
  • Mailing Address
    4240 Wilkie Way Palo Alto, CA 94306
  • Company Description
    Carmenta Bioscience, Inc., is a privately held medical technology company dedicated to improving maternal and fetal health. Spun-out of Stanford University School of Medicine in 2012, Carmenta Bioscience is currently developing a highly accurate, serum-based diagnostic test for preeclampsia.
  • Website
    http://www.carmentabio.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $2,000,000
  • Transaction Round
    Seed
  • Proceeds Purposes
    Proceeds from the financing will support development and commercialization of a new, proprietary test to better diagnose and predict preeclampsia in pregnant women.
  • M&A Terms
  • Venture Investor
    Investor

Trending on Xconomy